
News from RTTNews
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaDo you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top RTTNews News

Breast Cancer · United StatesGilead Sciences´ Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to results of a large trial presented on Saturday. The data is likely to change how patients are treated following a diagnosis for advanced triple-negative breast cancer, one expert said.See the Story
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
70% Center coverage: 17 sources
South Korea GDP contracts 0.1% in the first quarter amid political uncertainty
35% Right coverage: 26 sources
You've scrolled to the bottom of the feed, there are no more stories.